BRCA1 and breast carcinoma: Therefore, in breast cancer patients with reduced HspBP1 expression, DNA damage accumulates due to suppressed BRCA1 function, and the ability to remove these damaged cells is decreased as a result of suppressed Hsp70 proapoptotic functions which may synergistically trigger breast cancer progression.